Nwam LLC Anavex Life Sciences Corp. Transaction History
Nwam LLC
- $1.14 Billion
- Q2 2025
A detailed history of Nwam LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Nwam LLC holds 1,024,479 shares of AVXL stock, worth $9.31 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
1,024,479
Previous 1,000,351
2.41%
Holding current value
$9.31 Million
Previous $8.58 Million
10.04%
% of portfolio
0.83%
Previous 0.77%
Shares
9 transactions
Others Institutions Holding AVXL
# of Institutions
196Shares Held
31.9MCall Options Held
1.16MPut Options Held
804K-
Black Rock Inc. New York, NY6.39MShares$58.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$46.4 Million0.0% of portfolio
-
State Street Corp Boston, MA2.95MShares$26.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$18.4 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY973KShares$8.85 Million0.02% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $709M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...